Loss of erythromycin resistance genes from strains of Streptococcus pyogenes that have developed resistance to levofloxacin

Diagnostic Microbiology and Infectious Disease

Volumn 64, Issue 2, 2009, Pages 225-228

  Billal, Dewan Sakhawat ^a   Hotomi, Muneki ^a   Yan, Steve S ^b   Fedorko, Daniel P ^c   Shimada, Jun ^a   Fujihara, Keiji ^a   Yamanaka, Noboru ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c CLINICAL CENTER   (United States)

Author keywords

Erythromycin resistance; Fluoroquinolone resistance; Streptococcus pyogenes; Transconjugation

Indexed keywords

BACTERIAL PROTEIN; ERYTHROMYCIN; ERYTHROMYCIN RESISTANCE METHYLASE TR PROTEIN; LEVOFLOXACIN; MACROLIDE EFFLUX A PROTEIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM MUTANT; CONTROLLED STUDY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; CONJUGATION, GENETIC; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; GENE DELETION; GENE TRANSFER, HORIZONTAL; GENES, BACTERIAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; STREPTOCOCCUS PYOGENES;

EID: 67349121239     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.01.034     Document Type: Article

References (20)

1. Adhikari R.P., Scales G.C., Kobayashi K., Smith J.M., Berger-Bachi B., and Cook G.M. Vancomycin-induced deletion of the methicillin resistance gene mecA in Staphylococcus aureus. J. Antimicrob. Chemother. 54 (2004) 360-363
2. Billal D.S., Fedorko D.P., Yan S.S., Hotomi M., Fujihara K., Nelson N., and Yamanaka N. In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types. J. Antimicrob. Chemother. 59 (2007) 28-34
3. Brandi L., Falconi M., and Ripa S. Plasmid curing effect of trovafloxacin. FEMS Microbiol. Lett. 184 (2000) 297-302
4. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, M7-A7 (2006), CLSI, Wayne, PA
5. Fujita K., Murono K., Yoshikawa M., and Murai T. Decline of erythromycin resistance of group A streptococci in Japan. Pediatr. Infect. Dis. J. 13 (1994) 1075-1078
6. Hsueh P.R., Shyr J.M., and Wu J.J. Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan. Clin. Microbiol. Infect. 12 (2006) 296-298
7. Ikebe T., Hirasawa K., Suzuki R., Isobe J., Tanaka D., Katsukawa C., Kawahara R., Tomita M., Ogata K., Endoh M., Okuno R., and Watanabe H. Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections. Antimicrob. Agents Chemother. 49 (2005) 788-790
8. Malhotra-Kumar S., Lammens C., Chapelle S., Mallentjer C., Weyler J., and Goossens H. Clonal spread of fluoroquinolone non-susceptible Streptococcus pyogenes. J. Antimicrob. Chemother. 55 (2005) 320-325
9. Malhotra-Kumar S., Lammens C., Chapelle S., Wijdooghe M., Piessens J., Van Herck K., and Goossens H. Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003. Emerg. Infect. Dis. 11 (2005) 939-942
10. Montagnani F., Stolzuoli L., Zanchi A., Cresti S., and Cellesi C. Antimicrobial susceptibility of Streptococcus pyogenes and Streptococcus pneumoniae: surveillance from 1993 to 2004 in Central Italy. J. Chemother. 18 (2006) 389-393
11. Oliver M.A., Garcia-Delafuente C., Cano M.E., Perez-Hernandez F., Martinez-Martinez L., and Alberti S. Rapid decrease in the prevalence of macrolide-resistant group A streptococci due to the appearance of two epidemic clones in Cantabria (Spain). J. Antimicrob. Chemother. 60 (2007) 450-452
12. Orscheln R.C., Johnson D.R., Olson S.M., Presti R.M., Martin J.M., Kaplan E.L., and Storch G.A. Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics. J. Infect. Dis. 191 (2005) 1272-1279
13. Phillips I., Culebras E., Moreno F., and Baquero F. Induction of the SOS response by new 4-quinolones. J. Antimicrob. Chemother. 20 (1987) 631-638
14. Pumbwe L., Everett M.J., Hancock R.E., and Piddock L.J. Role of gyrA mutation and loss of OprF in the multiple antibiotic resistance phenotype of Pseudomonas aeruginosa G49. FEMS Microbiol. Lett. 143 (1996) 25-28
15. Reipert A., Ehlert K., Kast T., and Bierbaum G. Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin. Antimicrob. Agents Chemother. 47 (2003) 568-576
16. Soto S.M., Jimenez de Anta M.T., and Vila J. Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli by SOS-dependent or -independent pathways, respectively. Antimicrob. Agents Chemother. 50 (2006) 649-653
17. Taylor D.E., De Grandis S.A., Karmali M.A., and Fleming P.C. Transmissible plasmids from Campylobacter jejuni. Antimicrob. Agents Chemother. 19 (1981) 831-835
18. Uh Y., Hwang G.Y., Jang I.H., Cho H.M., Noh S.M., Kim H.Y., Kwon O., and Yoon K.J. Macrolide resistance trends in beta-hemolytic streptococci in a tertiary Korean hospital. Yonsei Med. J. 48 (2007) 773-778
19. Vila J., Simon K., Ruiz J., Horcajada J.P., Velasco M., Barranco M., Moreno A., and Mensa J. Are quinolone-resistant uropathogenic Escherichia coli less virulent?. J. Infect. Dis. 186 (2002) 1039-1042
20. Weber P., Filipecki J., Bingen E., Fitoussi F., Goldfarb G., Chauvin J.P., Reitz C., and Portier H. Genetic and phenotypic characterization of macrolide resistance in group A streptococci isolated from adults with pharyngo-tonsillitis in France. J. Antimicrob. Chemother. 48 (2001) 291-294